vimarsana.com

Latest Breaking News On - Nasdaq innv - Page 6 : vimarsana.com

InnovAge (NASDAQ:INNV) Trading Up 6 3%

InnovAge Holding Corp. (NASDAQ:INNV – Get Free Report) shares traded up 6.3% during trading on Thursday . The stock traded as high as $6.73 and last traded at $6.71. 35,300 shares were traded during mid-day trading, a decline of 4% from the average session volume of 36,888 shares. The stock had previously closed at $6.31. […]

InnovAge (NASDAQ:INNV) PT Lowered to $8 00 at The Goldman Sachs Group

InnovAge (NASDAQ:INNV – Get Free Report) had its price target dropped by equities research analysts at The Goldman Sachs Group from $9.00 to $8.00 in a report released on Wednesday, FlyOnTheWall reports. The Goldman Sachs Group’s price target indicates a potential upside of 26.78% from the stock’s previous close. InnovAge Stock Down 2.9 % INNV […]

Head to Head Analysis: InnovAge (INNV) vs The Competition

InnovAge (NASDAQ:INNV – Get Free Report) is one of 34 public companies in the “Health services” industry, but how does it contrast to its rivals? We will compare InnovAge to related businesses based on the strength of its analyst recommendations, profitability, valuation, earnings, dividends, risk and institutional ownership. Risk and Volatility InnovAge has a beta […]

InnovAge (INNV) & Its Peers Head-To-Head Survey

InnovAge (NASDAQ:INNV – Get Free Report) is one of 34 publicly-traded companies in the “Health services” industry, but how does it compare to its rivals? We will compare InnovAge to similar companies based on the strength of its risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Institutional and Insider Ownership 12.2% of InnovAge […]

InnovAge (INNV) vs Its Competitors Financial Review

InnovAge (NASDAQ:INNV – Get Free Report) is one of 35 publicly-traded companies in the “Health services” industry, but how does it compare to its competitors? We will compare InnovAge to similar companies based on the strength of its risk, earnings, institutional ownership, valuation, dividends, analyst recommendations and profitability. Insider and Institutional Ownership 12.2% of InnovAge […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.